Abstract
Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Current Pediatric Reviews
Title: Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?
Volume: 5 Issue: 4
Author(s): Karen Munro, Rosalyn J. Singleton, Elizabeth A. Edwards, Gregory J. Redding, Anne B. Chang and Catherine A. Byrnes
Affiliation:
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Abstract: Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Export Options
About this article
Cite this article as:
Munro Karen, J. Singleton Rosalyn, A. Edwards Elizabeth, J. Redding Gregory, B. Chang Anne and A. Byrnes Catherine, Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317342
DOI https://dx.doi.org/10.2174/157339609791317342 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances on Nitric Oxide in the Upper Airways
Current Medicinal Chemistry Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery BDNF Serum Concentrations Show No Relationship with Diagnostic Group or Medication Status in Neurodegenerative Disease
Current Alzheimer Research Quantifying Risk: The Role of Absolute and Relative Measures in Interpreting Risk of Adverse Reactions from Product Labels of Antipsychotic Medications
Current Drug Safety Polyunsaturated Fatty Acids in Emerging Psychosis
Current Pharmaceutical Design Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology
Current Molecular Imaging (Discontinued) The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Current Pharmaceutical Design 3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the Importance of Functional Groups for Antiparkinsonian Activity
Medicinal Chemistry Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives
Current Drug Metabolism Design and Synthesis of Dopaminergic Agonists
Current Medicinal Chemistry Effect of Brain Derived Neurotrophic Factor (BDNF) Gene Variants on Therapeutic Response and the Risk for Schizophrenia
Current Pharmacogenomics Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer’s and Parkinson’s Disease
Current Drug Metabolism Intrahypothalamic Administration of Modafinil Increases Expression of MAP-Kinase in Hypothalamus and Pons in Rats
CNS & Neurological Disorders - Drug Targets Selective Targeting of Muscarinic Receptors: Novel Therapeutic Approaches for Psychotic Disorders
Current Neuropharmacology Potential Therapeutic Strategies of Phytochemicals in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease
CNS & Neurological Disorders - Drug Targets Src Family Kinases in the Central Nervous System: Their Emerging Role in Pathophysiology of Migraine and Neuropathic Pain
Current Neuropharmacology